Brufsky A, Kim SB, Zvirbule Z, Eniu A, et al. A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysis. Ann Oncol 2021 Feb 1. pii: S0923-7534(21)00093.
PMID: 33539944